Literature DB >> 16088447

Neutrophils in innate immunity.

Qin Wang1, Claire M Doerschuk, Joseph P Mizgerd.   

Abstract

Neutrophils are an important component of innate immunity in the lungs. During bacterial pneumonia, neutrophils are recruited from the capillaries of the pulmonary circulation in the gas-exchanging regions of the lungs. This process requires the coordinated activation of many cells within the lungs, including neutrophils and capillary endothelial cells. Cellular activation during innate immune responses is mediated in part by tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1-initiated signaling through their receptors, activation of nuclear factor kappa B (NF-kappaB) and downstream gene transcription, endothelial cell signaling initiated by neutrophil adherence to intercellular adhesion molecule (ICAM)-1, and binding of leukocyte adhesion molecules to cellular and matrix ligands. These events are essential to effective host defense during pneumonia.

Entities:  

Year:  2004        PMID: 16088447     DOI: 10.1055/s-2004-822303

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  14 in total

1.  SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.

Authors:  Aili L Lazaar; Lisa E Sweeney; Alexander J MacDonald; Neil E Alexis; Chao Chen; Ruth Tal-Singer
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

2.  Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.

Authors:  Erick D McNair; Calvin R Wells; A M Qureshi; Colin Pearce; Gudrun Caspar-Bell; Kailash Prasad
Journal:  Int J Angiol       Date:  2011-03

Review 3.  Neutrophil recruitment to the lungs during bacterial pneumonia.

Authors:  Ann Craig; John Mai; Shanshan Cai; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

Review 4.  Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies.

Authors:  Marion Leick; Veronica Azcutia; Gail Newton; Francis W Luscinskas
Journal:  Cell Tissue Res       Date:  2014-02-23       Impact factor: 5.249

Review 5.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

6.  Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF(low) Alveolar Macrophages.

Authors:  Alan M Sanfilippo; Yoichi Furuya; Sean Roberts; Sharon L Salmon; Dennis W Metzger
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

7.  Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats.

Authors:  Kazuo Yoshida; Ryoichi Kondo; Qin Wang; Claire M Doerschuk
Journal:  Am J Respir Crit Care Med       Date:  2006-06-01       Impact factor: 21.405

8.  Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice.

Authors:  Matthew Marks; Tamika Burns; Maria Abadi; Beza Seyoum; Justin Thornton; Elaine Tuomanen; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

9.  Host susceptibility to gram-negative pneumonia after lung contusion.

Authors:  Vladislav A Dolgachev; Bi Yu; Julia M Reinke; Krishnan Raghavendran; Mark R Hemmila
Journal:  J Trauma Acute Care Surg       Date:  2012-03       Impact factor: 3.313

10.  Substance P mediates reduced pneumonia rates after traumatic brain injury.

Authors:  Sung Yang; David Stepien; Dennis Hanseman; Bryce Robinson; Michael D Goodman; Timothy A Pritts; Charles C Caldwell; Daniel G Remick; Alex B Lentsch
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.